U.S. STOCKS ON THE MOVE-Novo Nordisk, Block, Peloton Interactive
MiNK Therapeutics rises after data shows long-lasting remissions in tough cancers
Brief: MiNK Therapeutics Reports Durable Responses and Immune Reactivation with Allo-iNKT Cell Therapy agenT-797 in PD-1–Refractory Solid Tumors at SITC 2025
Brief: Mink Therapeutics Appoints Colonel(Ret.)John B. Holcomb To Board Of Directors
Mink Therapeutics Inc expected to post a loss of 55 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-American Battery Technology, News Corp, National Fuel Gas
U.S. STOCKS ON THE MOVE-American Battery Technology, News Corp, National Fuel Gas
U.S. STOCKS ON THE MOVE-Trade Desk, Lithia Motors, GitLab
MiNK Therapeutics tumbles after $50 mln stock offering filing
U.S. STOCKS ON THE MOVE-Tesla, General Motors, Chevron
U.S. STOCKS ON THE MOVE-Aerospace firms, Tesla, natgas companies
U.S. STOCKS ON THE MOVE-Boeing, Crypto stocks, Kraft Heinz
MiNK Therapeutics falls after over 700% surge in previous session
U.S. STOCKS ON THE MOVE-AeroVironment, Civista Bancshares, Meta
MiNK Therapeutics soars over 500% after cancer therapy shows complete remission
Brief: Mink Therapeutics Announces Publication Of Complete Remission
Mink Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Mink Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Mink Therapeutics Inc expected to post a loss of 50 cents a share - Earnings Preview